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Background:  The management of atrial septal defects (ASD), severe pulmonary hypertension (PAH) and Eisenmenger’s physiology 
remains largely controversial.
case:  A 52 year-old woman was referred with progressive dyspnea, systemic hypoxemia (91%) and clubbing. The echocardiogram 
showed markedly dilated right-sided chambers with shunt flow reversal across a moderate-size secundum ASD (Figure 1). On cardiac 
catheterization the baseline pulmonary-to-systemic flow (Qp:Qs) was 0.6, with elevated mean pulmonary artery pressure (PAP) of 76mmHg 
and pulmonary vascular resistance (PVR) of 13wu. Vasoreactivity challange with 100% oxygen and IV adenosine resulted in improved 
hypoxemia to 99%, an increase in Qp:Qs to 1.3, and a decrease in mean PAP (59mmHg) and PVR (3.4wu). Cardiac MRI showed an 
interrupted IVC with Azygous vein continuation and heterotaxy syndrome (Figure 2).
decision Making:  The presence of Eisenmenger’s physiology, severe PAH, and interrupted IVC creates a difficult decision-making 
process, since performing ASD closure is difficult and controversial. A multidisciplinary consensus was made to proceed with a “treat and 
repair approach”, supported in large by the remarkable vascular response noted during hemodynamic assessment. The patient was treated 
with continuous oxygen, oral sildenafil and bosentan. After 4 months, percutaneous transhepatic ASD closure was safely performed. Oral 
combination vasodilator therapy was maintained following ASD closure. At 1 year, the NYHA functional class improved from III to I, and the 
6-min walk test increased from 278m to 680m. Repeat catheterization showed Qp:Qs: 1, and a decrease in PAP and PVR to 50mmHg and 
6.9 wu, respectively.
conclusion:  This case illustrates the importance of a multidisciplinary team in complex decision-making, and the potential beneficial role 
of a “treat-and-repair approach” in patients with intracardiac shunt and Eisenmenger’s physiology, offering an alternative to patient that 
would have been previously considered inoperable with irreversible disease.
